Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis

WH Robinson, CM Lepus, Q Wang, H Raghu… - Nature Reviews …, 2016 - nature.com
Osteoarthritis (OA) has long been viewed as a degenerative disease of cartilage, but
accumulating evidence indicates that inflammation has a critical role in its pathogenesis …

Role of proinflammatory cytokines in the pathophysiology of osteoarthritis

M Kapoor, J Martel-Pelletier, D Lajeunesse… - Nature Reviews …, 2011 - nature.com
Osteoarthritis (OA) is associated with cartilage destruction, subchondral bone remodeling
and inflammation of the synovial membrane, although the etiology and pathogenesis …

Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis

D Gregori, G Giacovelli, C Minto, B Barbetta, F Gualtieri… - Jama, 2018 - jamanetwork.com
Importance Even though osteoarthritis is a chronic and progressive disease,
pharmacological agents are mainly studied over short-term periods, resulting in unclear …

Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations

J Sokolove, CM Lepus - Therapeutic advances in …, 2013 - journals.sagepub.com
Osteoarthritis (OA) has traditionally been classified as a noninflammatory arthritis; however,
the dichotomy between inflammatory and degenerative arthritis is becoming less clear with …

[HTML][HTML] EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis

G Sakellariou, PG Conaghan, W Zhang… - Annals of the …, 2017 - ard.bmj.com
The increased information provided by modern imaging has led to its more extensive use.
Our aim was to develop evidence-based recommendations for the use of imaging in the …

Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review

S Bacchi, P Palumbo, A Sponta… - Anti-Inflammatory & …, 2012 - ingentaconnect.com
Non-steroidal anti-inflammatory drugs (NSAIDs) are a group of often chemically unrelated
compounds with some common therapeutic actions and side effects. They have potent anti …

[HTML][HTML] Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review

SR Smith, BR Deshpande, JE Collins, JN Katz… - Osteoarthritis and …, 2016 - Elsevier
Objective Summarize the comparative effectiveness of oral non-steroidal anti-inflammatory
drugs (NSAIDs) and opioids in reducing knee osteoarthritis (OA) pain. Methods Two …

Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics

WM Oo, SPC Yu, MS Daniel… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Osteoarthritis (OA) is a leading cause of pain and disability among adults with a
current prevalence of around 15% and a predicted prevalence of 35% in 2030 for …

Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double‐blind, placebo‐controlled trial

LS Lohmander, S Hellot, D Dreher… - Arthritis & …, 2014 - Wiley Online Library
Objective To evaluate the efficacy and safety of intraarticular sprifermin (recombinant human
fibroblast growth factor 18) in the treatment of symptomatic knee osteoarthritis (OA). Methods …

Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial

T McAlindon, M LaValley, E Schneider, M Nuite, JY Lee… - Jama, 2013 - jamanetwork.com
Importance Knee osteoarthritis (OA), a disorder of cartilage and periarticular bone, is a
public health problem without effective medical treatments. Some studies have suggested …